Us Bancorp »

C4 Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $216 38 5.71
2024-03-31 $319 39 8.18
2022-03-31 $3.0k 118 25.42

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Us Bancorp

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
BlackRock
OrbiMed Advisors
Soleus Capital Management
Vanguard Group
Commodore Capital
State Street Corporation
Bank of America Corporation
Balyasny Asset Management
Silverarc Capital Management
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics